Emergent BioSolutions completes sales, deliveries of BioThrax to allied international governments

Links shared publicly online about this topic.

1,071
total visits

Emergent BioSolutions completes sales, deliveries of BioThrax to allied international governments

Emergent BioSolutions Inc. announced today that it has completed separate international sales and deliveries of BioThrax® (Anthrax Vaccine Adsorbed) to governments of several allied nations. The company's international sales efforts have resulted in these sales of an undisclosed number of BioThrax doses for aggregate revenue of approximately $2.3 million in the second quarter.

View full resource at news-medical.net

Tags: Vaccination, Anthrax, Vaccine